Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 2Genitourinary 2Other 1Head & Neck 1Gynecologic 1

Conditions

Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Breast Neoplasms 11Fallopian Tube Neoplasms 7Vulvar Neoplasms 6Uterine Neoplasms 6Carcinoma, Ovarian Epithelial 6Colorectal Neoplasms, Hereditary Nonpolyposis 5Colorectal Neoplasms 5Colonic Neoplasms 5Vaginal Neoplasms 4Neoplasms 4Uterine Cervical Dysplasia 3Rectal Neoplasms 3Prostatic Neoplasms 3Pelvic Neoplasms 3Hereditary Breast and Ovarian Cancer Syndrome 3Vomiting 2Urinary Bladder Neoplasms 2Sarcoma 2Obesity 2Nausea 2Motor Activity 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lymphedema 2Leukemia 2Kidney Neoplasms 2Gynecologic Cancer 2

Interventions

Cognitive Behavioral Therapy 2Behavior Therapy 2Uncertainty 1Therapeutics 1Surveys and Questionnaires 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Propranolol 1Methods 1Hepatitis B Vaccines 1Early Intervention, Educational 1Dehydroepiandrosterone 1Counseling 1Cognitive Restructuring 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Surveys and Questionnaires × Gynecologic × Clear all
NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡